Developer docs
API playgroundTry for free, no card

Search company profiles

IHU Liryc

Full company profile

uuid0022p4s

Namestring
IHU Liryc
Websiteurl
ihu-liryc.fr
Company typeenum
Private
Founded yearint
2011
Descriptiontext

IHU Liryc is a French non-profit academic medical research institute (Institut Hospitalo-Universitaire) founded in 2011 and headquartered in Pessac, France, with 51-100 employees. The institute focuses on cardiac rhythm diseases, with primary research activity in electrophysiology and computational cardiac modeling. Its primary patient population consists of individuals suffering from atrial fibrillation and heart failure, though the institute does not provide direct clinical care to these patients.

IHU Liryc's core technology is the development of personalized digital twin models of patients' hearts for atrial fibrillation treatment planning. These hybrid models integrate three distinct clinical data streams: MRI scans, electrical voltage measurements, and conduction velocity data. According to published research in the Journal of Physiology, the multi-modal hybrid approach identifies more ablation targets than MRI-only analysis, supporting more accurate treatment planning for persistent atrial fibrillation. Beyond digital twin research, the institute operates telemonitoring programs for heart failure patient follow-up, with leadership from cardiologists Dr. Mélèze Hocini (interim CEO) and Dr. Sylvain Ploux (CHU de Bordeaux).

The institute operates a non-commercial revenue model funded through charitable donations, academic research grants, and institutional partnerships. It collaborates closely with CHU de Bordeaux for clinical translation and with Queen Mary University of London for international research validation. Outreach is conducted via the 'Rencontres Connectées' educational webinar series and the institute's public website. There is no commercial pricing model, no commercial product distribution, and no disclosed revenue figures.

Short descriptiontext

IHU Liryc is a French non-profit academic medical research institute developing personalized digital twin heart models combining MRI, electrical, and conduction velocity data to improve atrial fibrillation treatment planning for cardiac rhythm disease patients.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersBordeaux, France
HQ citystring
Bordeaux
HQ countrystring
France
HQ regionstring
Europe
Markets served

Serves global market

Keyword5 values
cardiac electrophysiology research, digital heart twin modeling, atrial fibrillation treatment, heart rhythm disorders, cardiac telemonitoring
Industry2 codes
PRIMARYHLAHAFAI
Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
SECONDARYHLALAGAB
Cardiology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)
NAICS code2 codes
  • Scientific Research and Development Services5417
  • Computer Systems Design and Related Services54151
SIC code2 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Engineering, Accounting, Research, Management8700
Product category
Cardiac Electrophysiology Research
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Donations and Research Funding
TypeManaged Services
Description

IHU Liryc is funded through charitable donations ('Par votre générosité, vous donnez les moyens aux médecins et chercheurs de Liryc') which enable physicians and researchers to advance cardiac rhythm disease treatment for patients worldwide. Additional funding likely comes from academic research grants and institutional partnerships.

ihu-liryc.fr
Marketing channels2 records

Each record includes

Title, Type, Stage, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

IHU Liryc is a French university hospital research institute (Institut Hospitalo-Universitaire) that develops personalized digital twin heart models combining MRI scans, electrical voltage measurements, and conduction velocity data to improve atrial fibrillation treatment planning. The institute also operates telemonitoring programs for heart failure patients and disseminates cardiac rhythm disease research through clinical collaborations, academic publications, and educational events.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Hybrid digital twin models identify more ablation targets than MRI data alone
Product overview1 text field

IHU Liryc is a cardiac rhythm institute focused on heart rhythm diseases research and treatment. The institute develops and applies digital twin heart modeling technology for personalized atrial fibrillation treatment planning. In addition to digital twin research, IHU Liryc conducts tele-monitoring programs for heart failure patient follow-up, offering connected health services through specialized cardiology consultations featuring experts like Dre Mélèze Hocini and Dr Sylvain Ploux.

Product and service2 records
1Digital Heart Twin Models
CategoryResearch technology / cardiac digital twin modeling
Description

Personalized computational models of individual patients' hearts that simulate cardiac electrical activity to improve treatment planning for atrial fibrillation. The models integrate MRI scan data, electrical voltage measurements, and conduction velocity data to identify optimal ablation targets; currently in research phase, not yet part of routine clinical care.

2Heart Failure Telemonitoring Program
CategoryClinical telemonitoring / connected cardiology services
Description

Connected health telemonitoring services for heart failure patient follow-up, delivered through clinical collaboration with partner hospitals (notably CHU de Bordeaux) and showcased in the Rencontres Connectées educational series with experts such as Dre Mélèze Hocini and Dr Sylvain Ploux.

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-17
Description

International research collaboration with Queen Mary University of London researchers leading the cross-university study on digital twin heart models for atrial fibrillation treatment. Published in the Journal of Physiology, this partnership demonstrates the institute's role as a key contributor to cutting-edge cardiac research combining MRI, electrical voltage, and conduction velocity data.

2CHU de Bordeaux
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Clinical collaboration with CHU de Bordeaux hospital where Dr. Sylvain Ploux, cardiologist, participates in institute events and research. The partnership enables translation of research into clinical practice, particularly in telemonitoring and heart failure management.

ihu-liryc.fr
Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

GE HealthCare offers cardiac imaging, monitoring, and digital solutions across the cardiology workflow. It is a broad incumbent with overlapping capabilities in cardiac diagnostics and digital cardiology tools.

TypeBroad incumbent
Description

Siemens Healthineers is a major incumbent in cardiac imaging, diagnostics, and digital health. It provides overlapping capabilities in cardiovascular diagnostics and computational cardiac analysis as part of a much broader portfolio.

TypeEmerging player
Description

Volta Medical develops AI-based decision-support tools for cardiac electrophysiologists treating atrial fibrillation. It overlaps directly with IHU Liryc's AF treatment planning mission and represents a commercial peer pursuing AI-enabled electrophysiology.

4Acutus Medical
TypeDirect peer
Description

Acutus Medical develops cardiac mapping and ablation technologies for arrhythmia treatment. Its focus on electrophysiology mapping and ablation workflow makes it directly comparable to IHU Liryc's atrial fibrillation treatment planning research.

TypeDirect peer
Description

HeartFlow develops non-invasive coronary digital heart models (FFR-CT) for personalized cardiac diagnostics and treatment planning. It is the closest commercial analog to IHU Liryc's digital twin approach, focused on cardiology computational modeling to guide clinical decisions.

TypeBroad incumbent
Description

Philips provides cardiac imaging, patient monitoring, and connected care solutions for cardiology. It is a broad incumbent whose cardiology portfolio intersects with IHU Liryc's research areas in cardiac imaging and telemonitoring.

7Inria
TypeRegional player
Description

Inria is the French national institute for digital science research with active cardiac modeling teams (e.g., Carmen team). It is a regional research peer with overlapping cardiac digital twin and electrophysiology modeling research in France.

TypeEmerging player
Description

InHeart is a France-based company building AI-driven personalized cardiac digital twin models for ventricular tachycardia and other arrhythmia treatment planning. It is highly comparable to IHU Liryc given its focus on cardiac computational models for ablation and its French origin.

TypeRegional player
Description

Inserm is the French national institute for health and medical research, with cardiac electrophysiology research programs. It is a French research peer that conducts complementary cardiovascular and arrhythmia research within the same public research ecosystem.

10CardioSolv
TypeEmerging player
Description

CardioSolv is focused on computational cardiac modeling and simulation for ablation therapy planning. It is a niche emerging player in cardiac digital twin technology for arrhythmia treatment, comparable in scope to IHU Liryc's digital heart twin research.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability4 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

IHU Liryc

Cardiac Electrophysiology Researchihu-liryc.fr

IHU Liryc is a French non-profit academic medical research institute developing personalized digital twin heart models combining MRI, electrical, and conduction velocity data to improve atrial fibrillation treatment planning for cardiac rhythm disease patients.

What IHU Liryc does

IHU Liryc is a French non-profit academic medical research institute (Institut Hospitalo-Universitaire) founded in 2011 and headquartered in Pessac, France, with 51-100 employees. The institute focuses on cardiac rhythm diseases, with primary research activity in electrophysiology and computational cardiac modeling. Its primary patient population consists of individuals suffering from atrial fibrillation and heart failure, though the institute does not provide direct clinical care to these patients.

IHU Liryc's core technology is the development of personalized digital twin models of patients' hearts for atrial fibrillation treatment planning. These hybrid models integrate three distinct clinical data streams: MRI scans, electrical voltage measurements, and conduction velocity data. According to published research in the Journal of Physiology, the multi-modal hybrid approach identifies more ablation targets than MRI-only analysis, supporting more accurate treatment planning for persistent atrial fibrillation. Beyond digital twin research, the institute operates telemonitoring programs for heart failure patient follow-up, with leadership from cardiologists Dr. Mélèze Hocini (interim CEO) and Dr. Sylvain Ploux (CHU de Bordeaux).

The institute operates a non-commercial revenue model funded through charitable donations, academic research grants, and institutional partnerships. It collaborates closely with CHU de Bordeaux for clinical translation and with Queen Mary University of London for international research validation. Outreach is conducted via the 'Rencontres Connectées' educational webinar series and the institute's public website. There is no commercial pricing model, no commercial product distribution, and no disclosed revenue figures.

IHU Liryc firmographics

Firmographics
Name
IHU Liryc
Website
https://ihu-liryc.fr
Company type
Private
Founded year
2011
Operating status
Operating
Headcount range
101–250 employees
Short description
IHU Liryc is a French non-profit academic medical research institute developing personalized digital twin heart models combining MRI, electrical, and conduction velocity data to improve atrial fibrillation treatment planning for cardiac rhythm disease patients.
Ownership category
akta.pro rank

IHU Liryc industry classification

Industry
Product category
Cardiac Electrophysiology Research
NAICS
Scientific Research and Development Services (5417), Computer Systems Design and Related Services (54151)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Engineering, Accounting, Research, Management (8700)
akta.pro industry
PRIMARYHLAHAFAI
Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Cardiovascular Devices (Stents, Valves, Rhythm Management)
SECONDARYHLALAGAB
Cardiology Telemedicine Platforms
Healthcare & Life Sciences/Telehealth Platforms/Specialty Telemedicine Platforms (e.g., dermatology, cardiology, neurology)

Keywords

  • Cardiac electrophysiology research
  • Digital heart twin modeling
  • Atrial fibrillation treatment
  • Heart rhythm disorders
  • Cardiac telemonitoring

Where IHU Liryc is headquartered

Location

Headquarters

HQ city
Bordeaux
HQ country
France
HQ region
Europe

Markets served

IHU Liryc business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure

Revenue model

  1. Donations and Research Funding: IHU Liryc is funded through charitable donations ('Par votre générosité, vous donnez les moyens aux médecins et chercheurs de Liryc') which enable physicians and researchers to advance cardiac rhythm disease treatment for patients worldwide. Additional funding likely comes from academic research grants and institutional partnerships.

Go-to-market motion1 record

Marketing channels2 records

IHU Liryc product offering

Product offering

Core offering

IHU Liryc is a French university hospital research institute (Institut Hospitalo-Universitaire) that develops personalized digital twin heart models combining MRI scans, electrical voltage measurements, and conduction velocity data to improve atrial fibrillation treatment planning. The institute also operates telemonitoring programs for heart failure patients and disseminates cardiac rhythm disease research through clinical collaborations, academic publications, and educational events.

Product overview

IHU Liryc is a cardiac rhythm institute focused on heart rhythm diseases research and treatment. The institute develops and applies digital twin heart modeling technology for personalized atrial fibrillation treatment planning. In addition to digital twin research, IHU Liryc conducts tele-monitoring programs for heart failure patient follow-up, offering connected health services through specialized cardiology consultations featuring experts like Dre Mélèze Hocini and Dr Sylvain Ploux.

Differentiator

Problem solved

Functional benefit

Products and services

  • Digital Heart Twin Models Personalized computational models of individual patients' hearts that simulate cardiac electrical activity to improve treatment planning for atrial fibrillation. The models integrate MRI scan data, electrical voltage measurements, and conduction velocity data to identify optimal ablation targets; currently in research phase, not yet part of routine clinical care.
  • Heart Failure Telemonitoring Program Connected health telemonitoring services for heart failure patient follow-up, delivered through clinical collaboration with partner hospitals (notably CHU de Bordeaux) and showcased in the Rencontres Connectées educational series with experts such as Dre Mélèze Hocini and Dr Sylvain Ploux.

Quantifiable outcome

  • Hybrid digital twin models identify more ablation targets than MRI data alone

Companies that use IHU Liryc

Customer profile

Segments1 record

Ideal customer profiles2 records

IHU Liryc technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature1 record

IHU Liryc partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Queen Mary University of LondoncoreStrategic or Co-development Partner · 17 June 2026International research collaboration with Queen Mary University of London researchers leading the cross-university study on digital twin heart models for atrial fibrillation treatment. Published in the Journal of Physiology, this partnership demonstrates the institute's role as a key contributor to cutting-edge cardiac research combining MRI, electrical voltage, and conduction velocity data.
  • CHU de BordeauxcoreStrategic or Co-development PartnerClinical collaboration with CHU de Bordeaux hospital where Dr. Sylvain Ploux, cardiologist, participates in institute events and research. The partnership enables translation of research into clinical practice, particularly in telemonitoring and heart failure management.

Recent moves5 records

Expansion highlights4 records

IHU Liryc competitors and assessment

Company assessment

Broad incumbents

  • GE HealthCare: GE HealthCare offers cardiac imaging, monitoring, and digital solutions across the cardiology workflow. It is a broad incumbent with overlapping capabilities in cardiac diagnostics and digital cardiology tools.
  • Siemens Healthineers: Siemens Healthineers is a major incumbent in cardiac imaging, diagnostics, and digital health. It provides overlapping capabilities in cardiovascular diagnostics and computational cardiac analysis as part of a much broader portfolio.
  • Philips: Philips provides cardiac imaging, patient monitoring, and connected care solutions for cardiology. It is a broad incumbent whose cardiology portfolio intersects with IHU Liryc's research areas in cardiac imaging and telemonitoring.

Emerging players

  • Volta Medical: Volta Medical develops AI-based decision-support tools for cardiac electrophysiologists treating atrial fibrillation. It overlaps directly with IHU Liryc's AF treatment planning mission and represents a commercial peer pursuing AI-enabled electrophysiology.
  • InHeart: InHeart is a France-based company building AI-driven personalized cardiac digital twin models for ventricular tachycardia and other arrhythmia treatment planning. It is highly comparable to IHU Liryc given its focus on cardiac computational models for ablation and its French origin.
  • CardioSolv: CardioSolv is focused on computational cardiac modeling and simulation for ablation therapy planning. It is a niche emerging player in cardiac digital twin technology for arrhythmia treatment, comparable in scope to IHU Liryc's digital heart twin research.

Direct peers

  • Acutus Medical: Acutus Medical develops cardiac mapping and ablation technologies for arrhythmia treatment. Its focus on electrophysiology mapping and ablation workflow makes it directly comparable to IHU Liryc's atrial fibrillation treatment planning research.
  • HeartFlow: HeartFlow develops non-invasive coronary digital heart models (FFR-CT) for personalized cardiac diagnostics and treatment planning. It is the closest commercial analog to IHU Liryc's digital twin approach, focused on cardiology computational modeling to guide clinical decisions.

Regional players

  • Inria: Inria is the French national institute for digital science research with active cardiac modeling teams (e.g., Carmen team). It is a regional research peer with overlapping cardiac digital twin and electrophysiology modeling research in France.
  • Inserm: Inserm is the French national institute for health and medical research, with cardiac electrophysiology research programs. It is a French research peer that conducts complementary cardiovascular and arrhythmia research within the same public research ecosystem.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

IHU Liryc social profiles

Digital presence

IHU Liryc financial estimates

Financial estimate

Revenue estimate

Valuation estimate

IHU Liryc leadership team

Management profile

Number of profiles

Profiles1 record

IHU Liryc funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

IHU Liryc M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about IHU Liryc

What does IHU Liryc do?

IHU Liryc is a French university hospital research institute (Institut Hospitalo-Universitaire) that develops personalized digital twin heart models combining MRI scans, electrical voltage measurements, and conduction velocity data to improve atrial fibrillation treatment planning. The institute also operates telemonitoring programs for heart failure patients and disseminates cardiac rhythm disease research through clinical collaborations, academic publications, and educational events.

Is IHU Liryc a public or private company?

IHU Liryc is a private company. It is classified as nonprofit foundation owned and is currently operating.

When was IHU Liryc founded?

IHU Liryc was founded in 2011. It employs 101 to 250 people.

Where is IHU Liryc based?

IHU Liryc is headquartered in Bordeaux, France, in the Europe region.

How does IHU Liryc make money?

One revenue line is on record: donations and Research Funding.

Who are IHU Liryc's main competitors?

Broad incumbents on record are GE HealthCare, Siemens Healthineers and Philips. Emerging players are Volta Medical, InHeart and CardioSolv. Direct peers are Acutus Medical and HeartFlow. Regional players are Inria and Inserm.

Does IHU Liryc have an API?

No public API is recorded for IHU Liryc.

What industry is IHU Liryc in?

IHU Liryc's product category is Cardiac Electrophysiology Research. Its primary akta.pro industry code is HLAHAFAI, Hemodynamic Monitoring & Cardiac Diagnostics (Cath Lab, FFR/IVUS/OCT), with a secondary code of HLALAGAB, Cardiology Telemedicine Platforms. Its NAICS code is 5417 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals